As of 2026-09-08, the Fair Value of Biosergen AB (BIOSGN.ST) is -2.13 SEK. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.36 SEK, the upside of Biosergen AB is -256.86%.
With the market price of 1.36 SEK and our fair value calculation, Biosergen AB (BIOSGN.ST) is not a good investment. Investing in BIOSGN.ST stocks now will result in a potential loss of 256.86%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | - | 5Y Avg | |
| Net income | -34.32 | -34.05 | -27.04 | - | -31.80 | |
| YoY growth | -410.38% | 0.79% | 20.59% | - | -129.67% | |
| Market Cap (mil) | 199.50 |
| P/E | |
| Forward P/E |
| EPS | -0.43 |
| Avg earnings growth rate | -129.67% |
| TTM earnings | -32.32 |